Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
株式のランク #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
株価
$1.50
最終同期: 2026-09-21
時価総額
$3.63M
変化(1日)
-4.46%
変化(1年)
-72.68%
MY
取引 BioNexus Gene Lab Corp. (BGLC)

カテゴリー

BioNexus Gene Lab Corp.(BGLC)の収益
Jun 2026 時点の収益 TTM: $3.13M
BioNexus Gene Lab Corp. の最新の財務報告によると、現在の収益 (TTM) は $3.13M です。2023 年には $9.77M の収益があり、これは 2022 年の $10.93M と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BioNexus Gene Lab Corp. の収益履歴(2016 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $3.13M -67.13%
2024 $9.51M -2.66%
2023 $9.77M -10.60%
2022 $10.93M -18.21%
2021 $13.36M 17.31%
2020 $11.39M 8,872.03%
2019 $126.96K -40.21%
2018 $212.33K 97.18%
2017 $107.68K 0.00%
2016 0.00 0.00%
同業他社の収益
企業 収益 収益の差
$18.85B 602,635.06%
US
$8.75B 279,736.03%
US
- -
US
$25.01B 799,904.86%
US
- -
US